Dab2 was first identified as a tumor suppressor and a negative regulator of Wnt/β-catenin signaling and is an endocytic CLASP required for sorting of LDLR by recognizing FXNPXY sorting signal through its N-teminal PTB domain [46], [47]. The gene discussed is DAB2; the disease is neoplasm.